Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Imaging_Method,Ab-PET,detects,Pathological_Change,amyloid-beta pathology,Ab-PET检测淀粉样蛋白病理
Biomarker,neurogranin,correlates_with,Clinical_Stage,cognitive decline,neurogranin与认知衰退相关
Gene,APOE,has_allele,Risk_Factor,APOE e4,APOE基因的e4等位基因是阿尔茨海默病的风险因素
Research_Method,multimer detection system,tests,Biomarker,biomarkers in AD,多聚体检测系统用于测试阿尔茨海默病的生物标志物
Clinical_Test,ELISA,detects,Biomarker,amyloid-beta,ELISA检测淀粉样蛋白
Disease,Alzheimer's disease,has_biomarker,Biomarker,CSF Ab42/40,脑脊液Ab42/40是阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,mitochondrial dysfunction,阿尔茨海默病的病理改变包括线粒体功能障碍
Protein,tau protein,is_product_of,Gene,MAPT,tau蛋白由MAPT基因编码
Imaging_Method,18F-fluorodeoxyglucose PET,detects,Biomarker,glucose metabolism,18F-氟脱氧葡萄糖PET检测葡萄糖代谢
Biomarker,p-tau181,correlates_with,Clinical_Stage,early stage of AD,p-tau181与阿尔茨海默病早期阶段相关
Clinical_Test,CSF p-tau,measures,Biomarker,p-tau,脑脊液p-tau检测磷酸化tau蛋白
Protein,amyloid-beta,derived_from,Protein,amyloid precursor protein,淀粉样蛋白来源于淀粉样前体蛋白
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,systemic immunity,阿尔茨海默病的病理改变包括系统性免疫
Protein,tau,has_phosphorylation_site,Biomarker,p-tau231,tau蛋白在231位点磷酸化
Gene,APOE4,increases_risk_of,Disease,Alzheimer's disease,APOE4基因是阿尔茨海默病的重要风险因素
Disease,Alzheimer's disease,has_biomarker,Biomarker,neurofilament light chain,阿尔茨海默病的核心生物标志物包括神经丝轻链
Biomarker,microRNA-425,reflects,Pathological_Change,neuroinflammation,microRNA-425反映神经炎症
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,neuroimmunity,阿尔茨海默病的病理改变包括神经免疫
Biomarker,TREM2,correlates_with,Clinical_Stage,early stage of AD,TREM2与阿尔茨海默病早期阶段相关
Biomarker,Ab42,is_component_of,Pathological_Change,senile plaques,Ab42是老年斑的主要成分
Biomarker,SNAP25,correlates_with,Clinical_Stage,cognitive decline,SNAP25与认知衰退相关
Protein,amyloid-beta,accumulates_in,Brain_Region,brain,淀粉样蛋白在大脑中异常堆积
Clinical_Test,PrecivityAD TM,diagnoses,Disease,Alzheimer's disease,PrecivityAD TM用于诊断阿尔茨海默病
Biomarker,YKL-40,reflects,Pathological_Change,neuroinflammation,YKL-40反映神经炎症
Risk_Factor,age,affects,Biomarker,total tau,年龄影响总tau蛋白的水平
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,high cholesterol,高胆固醇是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_risk_factor,Gene,BACE1,BACE1基因是阿尔茨海默病的风险因素
Research_Method,mass spectrometry,analyzes,Biomarker,biomarkers in AD,质谱分析用于分析阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_biomarker,Biomarker,immunoglobulin,免疫球蛋白是阿尔茨海默病的生物标志物
Research_Method,ultrasensitive technologies,improves,Biomarker,plasma biomarkers,超灵敏技术提高了血浆生物标志物的检测范围
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,amyloid plaques,阿尔茨海默病的主要病理改变包括淀粉样斑块
Biomarker,p-tau181,is_used_for,Clinical_Test,diagnosis of AD,p-tau181用于阿尔茨海默病的诊断
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,low vitamin levels,低维生素水平是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_risk_factor,Gene,APOE4,APOE4基因是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,synaptic damage,阿尔茨海默病的病理改变包括突触损伤
Biomarker,p-tau217,correlates_with,Clinical_Stage,early stage of AD,p-tau217与阿尔茨海默病早期阶段相关
Biomarker,GFAP,correlates_with,Clinical_Stage,early stage of AD,GFAP与阿尔茨海默病早期阶段相关
Research_Method,cryo-electron microscopy,tests,Biomarker,biomarkers in AD,冷冻电镜用于测试阿尔茨海默病的生物标志物
Biomarker,S100B,reflects,Pathological_Change,astrocyte activation,S100B反映星形胶质细胞激活
Protein,tau,has_phosphorylation_site,Biomarker,p-tau205,tau蛋白在205位点磷酸化
Protein,tau protein,has_modification,Pathological_Change,hyperphosphorylation,tau蛋白的过度磷酸化是阿尔茨海默病的病理改变
Biomarker,NFL,reflects,Pathological_Change,axonal degeneration,NFL反映轴突变性
Treatment,donepezil,treats,Disease,Alzheimer's disease,多奈哌齐是治疗阿尔茨海默病的药物
Protein,tau protein,forms,Pathological_Change,neurofibrillary tangles,tau蛋白形成神经纤维缠结
Biomarker,t-tau,reflects,Pathological_Change,neurodegeneration,t-tau反映神经退行性变
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,high homocysteine,高同型半胱氨酸是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_risk_factor,Gene,PSEN2,PSEN2基因是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_biomarker,Biomarker,amyloid-beta,阿尔茨海默病的生物标志物包括淀粉样蛋白
Imaging_Method,tau-PET,detects,Pathological_Change,tau pathology,tau-PET检测tau病理
Disease,Alzheimer's disease,has_biomarker,Biomarker,tumor necrosis factor,肿瘤坏死因子是阿尔茨海默病的生物标志物
Risk_Factor,sex,affects,Biomarker,neurofilament light chain,性别影响神经丝轻链的水平
Disease,Alzheimer's disease,has_biomarker,Biomarker,amyloid-beta,阿尔茨海默病的核心生物标志物包括淀粉样蛋白
Research_Method,reduced graphene oxide field-effect transistor,tests,Biomarker,biomarkers in AD,还原氧化石墨烯场效应晶体管用于测试阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_biomarker,Biomarker,pathologic tau,阿尔茨海默病的核心生物标志物包括病理性tau蛋白
Biomarker,p-tau231,correlates_with,Clinical_Stage,early stage of AD,p-tau231与阿尔茨海默病早期阶段相关
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,activation of microglia and astrocytes,阿尔茨海默病的病理改变包括小胶质细胞和星形胶质细胞的激活
Clinical_Stage,mild cognitive impairment,progresses_to,Clinical_Stage,dementia,轻度认知障碍可能进展为痴呆
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,high triglycerides,高甘油三酯是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,oxidative stress,阿尔茨海默病的病理改变包括氧化应激
Biomarker,microRNA-425,correlates_with,Clinical_Stage,early stage of AD,microRNA-425与阿尔茨海默病早期阶段相关
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,neuroinflammation,阿尔茨海默病的病理改变包括神经炎症
Research_Method,single-molecule array,tests,Biomarker,biomarkers in AD,单分子阵列用于测试阿尔茨海默病的生物标志物
Research_Method,liquid chromatography-MS,tests,Biomarker,biomarkers in AD,液相色谱-质谱用于测试阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_biomarker,Biomarker,interleukin,白细胞介素是阿尔茨海默病的生物标志物
Biomarker,SNAP25,reflects,Pathological_Change,synaptic dysfunction,SNAP25反映突触功能障碍
Biomarker,p-tau217,is_used_for,Clinical_Test,diagnosis of AD,p-tau217用于阿尔茨海默病的诊断
Disease,Alzheimer's disease,has_risk_factor,Gene,PSEN1,PSEN1基因是阿尔茨海默病的风险因素
Biomarker,YKL-40,correlates_with,Clinical_Stage,early stage of AD,YKL-40与阿尔茨海默病早期阶段相关
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,diabetes,糖尿病是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_biomarker,Biomarker,tau protein,tau蛋白是阿尔茨海默病的生物标志物
Protein,tau,has_phosphorylation_site,Biomarker,p-tau181,tau蛋白在181位点磷酸化
Gene,TREM2,associated_with,Risk_Factor,Alzheimer's disease,TREM2基因与阿尔茨海默病风险相关
Research_Method,immunoprecipitation/MS,tests,Biomarker,biomarkers in AD,免疫沉淀/质谱用于测试阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,bacterial metabolites,细菌代谢物是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_risk_factor,Gene,APP,APP基因是阿尔茨海默病的风险因素
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,systemic inflammation,阿尔茨海默病的病理改变包括系统性炎症
Biomarker,Ab42/Ab40 ratio,balances,Biomarker,Ab production,Ab42/Ab40比值平衡了不同个体间的Ab产生
Treatment,donepezil,treats,Disease,Alzheimer's disease,多奈哌齐用于治疗阿尔茨海默病
Disease,Alzheimer's disease,has_biomarker,Biomarker,total tau,阿尔茨海默病的核心生物标志物包括总tau蛋白
Biomarker,TREM2,reflects,Pathological_Change,microglial activation,TREM2反映小胶质细胞激活
Biomarker,GAP43,correlates_with,Clinical_Stage,cognitive decline,GAP43与认知衰退相关
Imaging_Method,PET scans,diagnoses,Disease,Alzheimer's disease,正电子发射断层扫描用于诊断阿尔茨海默病
Imaging_Method,amyloid PET,detects,Biomarker,amyloid deposition,淀粉样蛋白PET检测淀粉样蛋白沉积
Disease,Alzheimer's disease,has_biomarker,Biomarker,complement families,补体家族是阿尔茨海默病的生物标志物
Research_Method,immunoassays,analyzes,Biomarker,biomarkers in AD,免疫测定用于分析阿尔茨海默病的生物标志物
Biomarker,neurogranin,reflects,Pathological_Change,synaptic dysfunction,neurogranin反映突触功能障碍
Biomarker,GFAP,reflects,Pathological_Change,astrocyte activation,GFAP反映星形胶质细胞激活
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,nutrition and metabolism,阿尔茨海默病的病理改变包括营养和代谢
Research_Method,ELISA,tests,Biomarker,biomarkers in AD,ELISA用于测试阿尔茨海默病的生物标志物
Disease,Alzheimer's disease,has_biomarker,Biomarker,plasma NFL,血浆神经丝轻链是阿尔茨海默病的生物标志物
Protein,tau,has_phosphorylation_site,Biomarker,t-tau,tau蛋白总水平
Clinical_Test,CSF examination,diagnoses,Disease,Alzheimer's disease,脑脊液检查用于诊断阿尔茨海默病
Clinical_Test,MMSE,evaluates,Clinical_Manifestation,cognitive function,简易精神状态检查用于评估认知功能
Clinical_Test,hippocampal atrophy,measures,Pathological_Change,hippocampal atrophy,海马萎缩检测海马体萎缩
Protein,tau,has_phosphorylation_site,Biomarker,p-tau217,tau蛋白在217位点磷酸化
Biomarker,S100B,correlates_with,Clinical_Stage,early stage of AD,S100B与阿尔茨海默病早期阶段相关
Biomarker,VILIP-1,reflects,Pathological_Change,neuronal injury,VILIP-1反映神经元损伤
Disease,Alzheimer's disease,has_pathological_change,Pathological_Change,apoptosis,阿尔茨海默病的病理改变包括细胞凋亡
Imaging_Method,MRI,detects,Pathological_Change,brain atrophy,MRI检测脑萎缩
Research_Method,immunomagnetic reduction,tests,Biomarker,biomarkers in AD,免疫磁减少用于测试阿尔茨海默病的生物标志物
Clinical_Test,cognitive decline,measures,Clinical_Manifestation,cognitive decline,认知衰退检测认知功能下降
Biomarker,GAP43,reflects,Pathological_Change,synaptic dysfunction,GAP43反映突触功能障碍
Research_Method,NDE assays,reduces,Biomarker,interference in blood,神经元来源的外泌体检测减少了血液中的干扰
Biomarker,p-tau231,is_used_for,Clinical_Test,diagnosis of AD,p-tau231用于阿尔茨海默病的诊断
Disease,Alzheimer's disease,has_risk_factor,Risk_Factor,hyperlipidemia,高脂血症是阿尔茨海默病的风险因素
